Key result
Mean platelet volume may predict cardiovascular disease risk and outcomes in patients with coronary artery disease, acting as a contributor rather than a simple marker.
Why the study?
To critically review the literature describing links between mean platelet volume and cardiovascular disease, with a focus on coronary artery disease.
Does mean platelet volume (MPV) predict cardiovascular disease risk and outcomes in patients with or at risk for coronary artery disease?
Does mean platelet volume (MPV) predict cardiovascular disease risk and outcomes in patients with or at risk for coronary artery disease?
Mean platelet volume, routinely measured in blood counts, may serve as a useful predictor of cardiovascular risk and outcomes in patients with coronary artery disease.
No takes yet. Share an insight, caveat, or question.
MPV may enhance CAD risk stratification on routine CBCs; leaves open causality and need for prospective trials before clinical adoption.
Pafili et al. (2019) conducted a review in Coronary artery disease. Mean platelet volume (MPV) was evaluated. Mean platelet volume may predict cardiovascular disease risk and outcomes in patients with coronary artery disease, acting as a contributor rather than a simple marker.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: